Eli Lilly and Co
Change company Symbol lookup
Select an option...
LLY Eli Lilly and Co
EVK Ever-Glory International Group Inc
TGODF Green Organic Dutchman Holdings Ltd
AVNI Arvana Inc
ARCC Ares Capital Corp
BCDA BioCardia Inc
AFG American Financial Group Inc
MGEN miRagen Therapeutics Inc
CVLG Covenant Logistics Group Inc
ARLO Arlo Technologies Inc
Go

Health Care : Pharmaceuticals | Large Cap Blend

Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or developed by its scientists. Its animal health business segment develops, manufactures and markets products for both food animals and companion animals. The Company's human pharmaceutical products include endocrinology products, neuroscience products, oncology products, immunology products and cardiovascular products. The Company's animal health products segment includes products for food animals and products for companion animals. As of December 31, 2018, the Company manufactured and distributed its products through facilities in the United States, Puerto Rico and 14 other countries.

Postmarket

Last Trade: Delayed
$145.56

Change Since Close Change Since Close Postmarket extended hours change is based on the last price at the end of the regular hours period. Premarket extended hours change is based on the day's regular session close.: 0.00 (0.00%)

Bid: --

Ask: --

B/A Size: --

Market Hours

Closing Price: $145.56

Day's Change: -0.09 (-0.06%)

Bid: --

Ask: --

B/A Size: --

Day's High: 148.06

Day's Low: 145.26

Volume (Average) Volume: 3,946,626 10-day average volume: 3,980,533: 3,946,626

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

The risk of loss in trading futures can be substantial. Clients must consider all relevant risk factors, including their own personal financial situation, before trading. Margin and level 2 options approval or higher is required. Not all account owners will qualify.

Dividends are converted to USD using the current rate of exchange at the end of the business day on the day the dividend went EX. Earnings are converted to USD using the current rate of exchange at the end of the business day on the day earnings were announced.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.

Postmarket

Change Since Close

Market Hours